Skip to main content

Ligand Pharmaceuticals Inc

LGNDZ
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000886163

In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $16 in total; no superinvestor holds it.

Other share classesLGNDLGNXZLGNYZLGNZZ

Superinvestors holding LGNDZ, Q2 2026

See all superinvestors

No superinvestor reported holding LGNDZ in Q2 2026.